Literature DB >> 8596638

A Grb2-associated docking protein in EGF- and insulin-receptor signalling.

M Holgado-Madruga1, D R Emlet, D K Moscatello, A K Godwin, A J Wong.   

Abstract

The protein Grb2 plays a central role in signalling by receptor protein-tyrosine kinases, where its SH2 domain binds to the receptor and its two SH3 domains link to effectors. One target effector is Sos, so Grb2 links receptor protein-tyrosine kinases with the Ras signalling pathway. The SH3 domains can also couple to other signalling proteins, including Vav, c-Abl and dynamin. We have identified several bands in glial and medulloblastoma tumours that are recognized by Grb2 but these did not correspond to any known protein. Here we use recombinant Grb2 to isolate a complementary DNA called Gab1 (for Grb2-associated binder-1). Gab1 shares amino-acid homology and several structural features with IRS-1 (insulin-receptor substrate-1; refs 6,7), is a substrate of the EGF and insulin receptors, and can act as a docking protein for several SH2-containing proteins. Over-expression of Gab1 enhances cell growth and results in transformation. We conclude that Gab1 is a new protein in EGF and insulin receptor signalling which could integrate signals from different systems.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596638     DOI: 10.1038/379560a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  181 in total

1.  Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps.

Authors:  A M O'Reilly; S Pluskey; S E Shoelson; B G Neel
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation.

Authors:  M Itoh; Y Yoshida; K Nishida; M Narimatsu; M Hibi; T Hirano
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

3.  SHPS-1 regulates integrin-mediated cytoskeletal reorganization and cell motility.

Authors:  K Inagaki; T Yamao; T Noguchi; T Matozaki; K Fukunaga; T Takada; T Hosooka; S Akira; M Kasuga
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

Review 4.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance.

Authors:  A Virkamäki; K Ueki; C R Kahn
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

5.  The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M Holgado-Madruga; I Royal; M A Naujokas; T M Fournier; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

6.  The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.

Authors:  D Tulasne; R Paumelle; K M Weidner; B Vandenbunder; V Fafeur
Journal:  Mol Biol Cell       Date:  1999-03       Impact factor: 4.138

7.  Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversion.

Authors:  T M Fournier; L Lamorte; C R Maroun; M Lupher; H Band; W Langdon; M Park
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

8.  The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.

Authors:  C R Maroun; M A Naujokas; M Holgado-Madruga; A J Wong; M Park
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

9.  ShcA tyrosine phosphorylation sites can replace ShcA binding in signalling by middle T-antigen.

Authors:  P R Nicholson; S Empereur; H R Glover; S M Dilworth
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

10.  Critical role for the docking-protein FRS2 alpha in FGF receptor-mediated signal transduction pathways.

Authors:  Y R Hadari; N Gotoh; H Kouhara; I Lax; J Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.